IDH1-mutated relapsed or refractory AML: current challenges and future prospects

Megías-Vericat JE, Ballesta-López O, Barragán E, Montesinos P

Blood and Lymphatic Cancer: Targets and Therapy 2019, 9:19-32

Published Date: 27 June 2019